Molecular Electrostatic Potential Studies on Some Nitroimidazolyl and Nitroheterocyclic Compounds

References

• Adams G.E. Hypoxic cell radiosensitizers for radiotherapy. Cancer: A Comprehensive Treatise, F. Becker. Plenum, New York 1977; 6: 181–223
   Google Scholar
• Adams G.E., Cooke M.S. Electron-affinic Sensitization. I. A structural basis for chemical radiosensitizers in bacteria. International Journal of Radiation Biology 1969; 15: 457–471
   Web of Science ®Google Scholar
• Adams G.E., Flockhart I.R., Smithen C.E., Stratford I.J., Wardmam P., Watte M.E. Electron-affinic sensitization. VII. A correlation between structures, one-electron reduction potentials and efficiencies of nitroimidazoles as hypoxic cell radiosensitizers. Radiation Research 1976; 67: 9–20
   PubMed Web of Science ®Google Scholar
• Adams G.E., Clarke E.D., Flockhart I.R., Jacobs R.S., Sehmi D.S., Stratford I.J., Wardman P., Watts M.E. Structure-activity relationship in the development of hypoxic cell radiosensitizers. I. Sensitization efficiency. International Journal of Radiation Biology 1979; 35: 133–150
   Web of Science ®Google Scholar
• Adams G.E., Ahmed I., Sheldon P.W., Stratford I.J. Radiation sensitization and chemopotentiation: RSU 1069, a compound more efficient than misonidazole in vitro and in vivo. British Journal of Cancer 1984; 49: 571–578
   PubMed Web of Science ®Google Scholar
• Balton N.M., Peeters O.M., De Ranter C.J. 2-(2-Methyl-5-nitro-1-imidazoly)ethanol (Metronidazole). Acta Crystallographica 1979; B35: 2465–2467
   Google Scholar
• Barnes J.H., Ashwood-Smith M.J., Bridges B.A. Radiosensitization of bacterial cells by carbonyl compounds. International Journal of Radiation Biology 1969; 15: 285–288
   Web of Science ®Google Scholar
• Brown D.M., Parker E., Brown J.M. In vitro radiosensitization and cytotoxicity of 2-nitroimidazoles with different lipophilicities. Radiation Research 1980; 83: 397–398
   Web of Science ®Google Scholar
• Brown J.M., Yu N.Y., Brown D.M., Lee W.W. SR-2508: A 2-nitroimidazole amide which should be superior to misonidazole as a radiosensitizer for clinical use. International Journal of Radiation Oncology, Biology and Physics 1981; 7: 695–705
   PubMed Web of Science ®Google Scholar
• Chapman J.D., Reuvers A.P., Borsa J. Effectiveness of nitrofuran derivatives in sensitizing hypoxic mammalian cells to X-rays. British Journal of Radiology 1973; 46: 623–630
   PubMed Web of Science ®Google Scholar
• Dennis M.F., Stratford M.R.L., Wardman P., Watts M.E. Cellular uptake of misonidazole and analogues with acidic or basic functions. International Journal of Radiation Biology 1985; 47: 629–643
   Web of Science ®Google Scholar
• Dische S., Saunders M.I., Adams G.E., Flockhart I.R. Clinical testing of the radiosensitizer Ro 07-0582, Experiment with multiple dose. British Journal of Cancer 1977; 35: 567–579
   PubMed Web of Science ®Google Scholar
• Kim J.K.S., Boyko E.R. The Crystal Structure of p-nitroacetophenone. Acta Crystallographica 1973; B29: 1141–1141
   Google Scholar
• Ling Liming, Xu Shujuan, Luo Zuyu, Wu Jian. Quantum chemical studies of radiosensitizers by the CNDO/2 method. I. Relationship between the superdelocalizability and the sensitizing efficiency. Journal of Molecular Science (Wuhan, China) 1985; 3: 127–134
   Google Scholar
• Luo Zuyu, Zhu Anqi, Xue Yongquan, Xu Shujuan, Li Zhenming. The role of molecular electrostatic potentials in radiosensitization. Proceedings of 2nd China-Japan Bilateral Symposium on Radiosensitization. SianChina 1986; 91–96
   Google Scholar
• Petrongold C., Preston J.T.H., Kaufman J.J. Ab initio LCAO-MO-SCF calculation of the electrostatic molecular potential of chlorpromazine and promazine. International Journal of Quantum Chemistry 1978; 13: 457–468
   Web of Science ®Google Scholar
• Pople J.A., Beveridge D.L. Approximate Molecular Orbital Theory. McGraw-Hill, New York 1970
   Google Scholar
• Richard W.G. Quantum Pharmacology. Butterworths, London 1977; 130–130
   Google Scholar
• Singh B.B. Radiosensitization. Atomic Energy Review 1980; 18: 171–222
   Google Scholar
• Smithen C.E., Clarke E.D., Dale J.A. Novel (nitro-1-imidazolyl)-alkanolamines as potential radiosensitizers with improved therapeutic properties. Radiation Sensitizers: Their Use in the Clinical Management of Cancer, L.W. Brady. Masson, New York 1980; 22–22
   Google Scholar
• Spackman M.A., Stewart R.F. Electrostatic potentials in crystals. Chemical Application of Atomic and Molecular Electrostatic Potentials, P. Politzer, D.G. Truhiar. Plenum, New York 1980; 407–426
   Google Scholar
• Stratford M.R.L., Minchinton A.I., Hiu S.A., McNally N.J., Williams M.V. Pharmacokinetic studies using multiple administration of Ro03-8799, a 2-nitroimidazole radiosensitizer. International Journal of Radiation Oncology, Biology and Physics 1982; 8: 469–471
   PubMed Web of Science ®Google Scholar
• Urtasun R.C., Chapman J.D., Feldstein M.L., Band R.P., Rabin H.R., Wilson A.F., Marynowski B., Starreveld E., Shitka T. Peripheral neurophathy related to misonidazole: Incidente and Pathology. British Journal of Cancer 1978; 37(III)271–275
   Google Scholar
• Walling J., Stratford I.J., Adams G.E., Stephene M.A. Dual-function radiation sensitizers and bioreductive drugs: factors affecting cellular uptake and sensitizing efficiency in analogues of RSU1069. International Journal of Radiation Biology 1988; 53: 641–649
   Web of Science ®Google Scholar
• Watts M.E., Dennis M.F., Jones N.R., Stratford M.R.L. A comparison of the intracellular uptake and radio-sensitization efficiency in different media of uncharged 2-nitroimidazoles of varying lipophilicity. International Journal of Radiation Biology 1987; 52: 359–370
   Web of Science ®Google Scholar
• Xu Shujuan, Lin Liming, Lu Zuyu, Wu Jian. Quantum chemical studies of radiosensitizers by the CNDO/2 method. II. Comparison between molecular electrostatic potential maps. Journal of Molecular Science (Wuhan, China) 1986; 4: 11–18
   Google Scholar